# Provectus Biopharmaceuticals, Inc.: Form DEF 14A, filed May 1, 2023

- Company: [Provectus Biopharmaceuticals, Inc.](/companies/pvct.md) (CIK 315545)
- Form: DEF 14A
- Filed: 2023-05-01
- Accepted by EDGAR: May 1, 2023, 13:58 ET
- Period: 2023-05-01
- Accession: 0001493152-23-014910
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/315545/000149315223014910/formdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/315545/000149315223014910/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/315545/000149315223014910/formdef14a.htm

Filed May 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-014910. Last ingested by Listed: Oct 30, 2026, 11:33 ET. No prices; not investment advice.